前列腺癌免疫冷微环境的瘤内在调节者
1Department of Urology, Emory University School of Medicine, Atlanta, GA, USA; Division of Hematology/Oncology, Department of Medicine, Northwestern University, Chicago, IL, USA.
Trends in endocrinology and metabolism: TEM
|January 3, 2025
概括
前列腺癌 (PC) 是一种免疫冷瘤,通常缺乏抗癌免疫细胞. 向PC细胞是提高患者免疫疗法的有效性的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 前列腺癌 (PC) 具有免疫冷瘤的特征,通常缺乏显著的抗瘤免疫细胞透.
- 先进的形式,如神经内分泌PC,可以没有免疫细胞,限制治疗选择.
- 由于这种免疫抑制瘤微环境,大多数PC患者无法从当前的免疫疗法中受益.
研究的目的:
- 探索前列腺瘤细胞中的遗传和表观遗传因素,这些因素创造了一个免疫抑制的微环境.
- 了解导致前列腺癌免疫冷状态的机制.
- 确定克服前列腺癌免疫逃避的策略.
主要方法:
- 本综述综合了目前关于前列腺癌遗传和表观遗传调节者的研究.
- 它分析了这些内在瘤细胞因素如何影响瘤微环境.
- 讨论的重点是导致免疫抑制的因素.
主要成果:
- 前列腺癌细胞内的遗传和表观遗传改变显著塑造了瘤微环境.
- 这些内在因素是PC中观察到的免疫感冒表型的主要贡献者.
- 免疫细胞透的缺乏是这些瘤内在性质的直接结果.
结论:
- 通过向前列腺癌细胞来修改瘤微环境至关重要.
- 这种方法对于使现有和新兴PC免疫疗法的疗效至关重要.
- 直接向癌细胞提供了一个有希望的策略,以提高前列腺癌的免疫治疗结果.
相关概念视频
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
01:27Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K